Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model

Peritoneal dialysis (PD) is a common treatment for patients with reduced or absent renal function. Long-term PD leads to peritoneal injury with structural changes and functional decline. At worst, peritoneal injury leads to encapsulating peritoneal sclerosis (EPS), which is a serious complication of PD. In order to carry out PD safely, it is important to define the mechanism of progression of peritoneal injury and EPS. We prepared rat models of peritoneal injury by intraperitoneal administration of glucose degradation products, such as methylglyoxal (MGO) or formaldehyde (FA), chlorhexidine gluconate (CG), and talc. In rats treated with MGO, peritoneal fibrous thickening with the appearance of basophilic spindle cells with podoplanin, cytokeratin, and α-smooth muscle actin at the surface of the peritoneum was observed. These cells may have been derived from mesothelial cells by epithelial-to-mesenchymal transition. In FA- or CG-treated rats, the peritoneum was thickened, and mesothelial cells were absent at the surface of the peritoneum. The CG- or MGO-treated rats presented with a so-called abdominal cocoon. In the talc-treated rats, extensive peritoneal adhesion and peritoneal thickening were observed. MGO-induced peritoneal injury model may reflect human histopathology and be suitable to analyze the mechanism of progression of peritoneal injury and EPS.

[1]  A. Morinobu,et al.  Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. , 2013, Molecular immunology.

[2]  G. Ott,et al.  Histological Criteria for Encapsulating Peritoneal Sclerosis – A Standardized Approach , 2012, PloS one.

[3]  M. Kimmel,et al.  Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  D. Gilroy,et al.  A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis , 2010, FEBS letters.

[5]  David W. Johnson,et al.  Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. , 2010, Kidney international.

[6]  A. Davenport,et al.  The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  K. Simpson,et al.  Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[8]  E. Kusano,et al.  Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Y. Asano,et al.  Peritoneal Injury by Methylglyoxal in Peritoneal Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  C. Hoff Experimental Animal Models of Encapsulating Peritoneal Sclerosis , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  H. Oda,et al.  Pathology of Encapsulating Peritoneal Sclerosis , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  M. Yáñez-Mó,et al.  Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. , 2005, Current opinion in investigational drugs.

[13]  N. Kimura,et al.  Podoplanin as a marker for mesothelioma , 2005, Pathology international.

[14]  J. Jönsson,et al.  PD Fluids Contain High Concentrations of Cytotoxic GDPs Directly after Sterilization , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  Y. Asano,et al.  Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  Y. Tomino,et al.  Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. , 2004, Kidney international.

[17]  T. Hosoya,et al.  Hyper-Vascular Change and Formation of Advanced Glycation Endproducts in the Peritoneum Caused by Methylglyoxal and the Effect of an Anti-Oxidant, Sodium Sulfite , 2003, American Journal of Nephrology.

[18]  J. Jimenez-Heffernan,et al.  Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. , 2003, The New England journal of medicine.

[19]  Y. Asano,et al.  Increase of matrix metalloproteinase‐2 in dialysate of rat sclerosing encapsulating peritonitis model , 2002 .

[20]  A. Shimizu,et al.  An experimental sclerosing encapsulating peritonitis model in mice. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  Y. Asano,et al.  Serial analysis of matrix metalloproteinase-2 in dialysate of rat sclerosing peritonitis models , 2001, Clinical and Experimental Nephrology.

[22]  S. Mujais,et al.  Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and Treatment , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  W. Geis,et al.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. , 1980, Archives of internal medicine.